|
1
|
Niriayo YL, Ibrahim S, Kassa TD, Asgedom
SW, Atey TM, Gidey K, Demoz GT and Kahsay D: Practice and
predictors of self-care behaviors among ambulatory patients with
hypertension in Ethiopia. PLoS One. 14:e02189472019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Agbor LN, Nair AR, Wu J, Lu KT, Davis DR,
Keen HL, Quelle FW, McCormick JA, Singer JD and Sigmund CD:
Conditional deletion of smooth muscle Cullin-3 causes severe
progressive hypertension. JCI Insight. 5:e1297932019. View Article : Google Scholar
|
|
3
|
Chen A, Huang BS, Wang HW, Ahmad M and
Leenen FH: Knockdown of mineralocorticoid or angiotensin II type 1
receptor gene expression in the paraventricular nucleus prevents
angiotensin II hypertension in rats. J Physiol. 592:3523–3536.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schaeffer C, Izzi C, Vettori A,
Pasqualetto E, Cittaro D, Lazarevic D, Caridi G, Gnutti B, Mazza C,
Jovine L, et al: Autosomal dominant tubulointerstitial kidney
disease with adult onset due to a novel renin mutation mapping in
the mature protein. Sci Rep. 9:116012019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wannberg J, Isaksson R, Bremberg U,
Backlund M, Sävmarker J, Hallberg M and Larhed M: A convenient
transesterification method for synthesis of AT2 receptor ligands
with improved stability in human liver microsomes. Bioorg Med Chem
Lett. 28:519–522. 2018. View Article : Google Scholar
|
|
6
|
Kemp BA, Howell NL, Keller SR, Gildea JJ,
Shao W, Navar LG and Carey RM: Defective renal angiotensin III and
AT2 receptor signaling in prehypertensive spontaneously
hypertensive rats. J Am Heart Assoc. 8:e0120162019. View Article : Google Scholar :
|
|
7
|
Assersen KB, Sumners C and Steckelings UM:
The renin-angiotensin system in hypertension, a constantly renewing
classic: Focus on the angiotensin AT2-receptor. Can J Cardiol.
36:683–693. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Siragy HM: The potential role of the
angiotensin subtype 2 receptor in cardiovascular protection. Curr
Hypertens Rep. 11:260–262. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Kloet AD, Steckelings UM and Sumners C:
Protective angiotensin type 2 receptors in the brain and
hypertension. Curr Hypertens Rep. 19:462017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jackson L, Eldahshan W, Fagan SC and Ergul
A: Within the brain: The renin angiotensin system. Int J Mol Sci.
19:8762018. View Article : Google Scholar :
|
|
11
|
Chrysant SG: The role of angiotensin II
receptors in stroke protection. Curr Hypertens Rep. 14:202–208.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Su Q, Huo CJ, Li HB, Liu KL, Li X, Yang Q,
Song XA, Chen WS, Cui W, Zhu GQ, et al: Renin-angiotensin system
acting on reactive oxygen species in paraventricular nucleus
induces sympathetic activation via AT1R/PKCγ/Rac1 pathway in
salt-induced hypertension. Sci Rep. 7:431072017. View Article : Google Scholar
|
|
13
|
Cardoso LM, Colombari E and Toney GM:
Endogenous hydrogen peroxide in the hypothalamic paraventricular
nucleus regulates sympathetic nerve activity responses to
L-glutamate. J Appl Physiol (1985). 113:1423–1431. 2012. View Article : Google Scholar
|
|
14
|
Kang YM, Zhang ZH, Xue B, Weiss RM and
Felder RB: Inhibition of brain proinflammatory cytokine synthesis
reduces hypothalamic excitation in rats with ischemia-induced heart
failure. Am J Physiol Heart Circ Physiol. 295:H227–H236. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guggilam A, Patel KP, Haque M, Ebenezer
PJ, Kapusta DR and Francis J: Cytokine blockade attenuates
sympathoexcitation in heart failure: Cross-talk between nNOS, AT-1R
and cytokines in the hypothalamic paraventricular nucleus. Eur J
Heart Fail. 10:625–634. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu GQ, Xu Y, Zhou LM, Li YH, Fan LM, Wang
W, Gao XY and Chen Q: Enhanced cardiac sympathetic afferent reflex
involved in sympathetic overactivity in renovascular hypertensive
rats. Exp Physiol. 94:785–794. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhong MK, Duan YC, Chen AD, Xu B, Gao XY,
De W and Zhu GQ: Paraventricular nucleus is involved in the central
pathway of cardiac sympathetic afferent reflex in rats. Exp
Physiol. 93:746–753. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen AD, Zhang SJ, Yuan N, Xu Y, De W, Gao
XY and Zhu GQ: Angiotensin AT1 receptors in paraventricular nucleus
contribute to sympathetic activation and enhanced cardiac
sympathetic afferent reflex in renovascular hypertensive rats. Exp
Physiol. 96:94–103. 2011. View Article : Google Scholar
|
|
19
|
Sakai K, Agassandian K, Morimoto S,
Sinnayah P, Cassell MD, Davisson RL and Sigmund CD: Local
production of angiotensin II in the subfornical organ causes
elevated drinking. J Clin Invest. 117:1088–1095. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dampney RA, Tan PS, Sheriff MJ, Fontes MA
and Horiuchi J: Cardiovascular effects of angiotensin II in the
rostral ventrolateral medulla: The push-pull hypothesis. Curr
Hypertens Rep. 9:222–227. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Krause EG, Melhorn SJ, Davis JF, Scott KA,
Ma LY, de Kloet AD, Benoit SC, Woods SC and Sakai RR: Angiotensin
type 1 receptors in the subfornical organ mediate the drinking and
hypothalamic-pituitary-adrenal response to systemic isoproterenol.
Endocrinology. 149:6416–6424. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nunes FC and Braga VA: Chronic angiotensin
II infusion modulates angiotensin II type I receptor expression in
the subfornical organ and the rostral ventrolateral medulla in
hypertensive rats. J Renin Angiotensin Aldosterone Syst.
12:440–445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Z and Ferguson AV: Subfornical organ
efferents to paraventricular nucleus utilize angiotensin as a
neurotransmitter. Am J Physiol. 265:R302–R309. 1993.PubMed/NCBI
|
|
24
|
Huang BS, Ahmadi S, Ahmad M, White RA and
Leenen FH: Central neuronal activation and pressor responses
induced by circulating ANG II: Role of the brain
aldosterone-'ouabain' pathway. Am J Physiol Heart Circ Physiol.
299:H422–H430. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krause EG, de Kloet AD, Scott KA, Flak JN,
Jones K, Smeltzer MD, Ulrich-Lai YM, Woods SC, Wilson SP, Reagan
LP, et al: Blood-borne angiotensin II acts in the brain to
influence behavioral and endocrine responses to psychogenic stress.
J Neurosci. 31:15009–15015. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kleiber AC, Zheng H, Sharma NM and Patel
KP: Chronic AT1 receptor blockade normalizes NMDA-mediated changes
in renal sympathetic nerve activity and NR1 expression within the
PVN in rats with heart failure. Am J Physiol Heart Circ Physiol.
298:H1546–H1555. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leenen FHH, Blaustein MP and Hamlyn JM:
Update on angiotensin II: New endocrine connections between the
brain, adrenal glands and the cardiovascular system. Endocr
Connect. 6:R131–R145. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mendelsohn FA, Quirion R, Saavedra JM,
Aguilera G and Catt KJ: Autoradiographic localization of
angiotensin II receptors in rat brain. Proc Natl Acad Sci USA.
81:1575–1579. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Leenen FHH, Wang HW and Hamlyn JM: Sodium
pumps, ouabain and aldosterone in the brain: A neuromodulatory
pathway underlying salt-sensitive hypertension and heart failure.
Cell Calcium. 86:1021512020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nagatomo T, Inenaga K and Yamashita H:
Transient outward current in adult rat supraoptic neurones with
slice patch-clamp technique: Inhibition by angiotensin II. J
Physiol. 485:87–96. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang CR, Phillips MI and Renaud LP:
Angiotensin II receptor activation depolarizes rat supraoptic
neurons in vitro. Am J Physiol. 263:R1333–R1338. 1992.PubMed/NCBI
|
|
32
|
Ozaki Y, Soya A, Nakamura J, Matsumoto T
and Ueta Y: Potentiation by angiotensin II of spontaneous
excitatory post-synaptic currents in rat supraoptic magnocellular
neurones. J Neuroendocrinol. 16:871–879. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Moellenhoff E, Blume A, Culman J,
Chatterjee B, Herdegen T, Lebrun CJ and Unger T: Effect of
repetitive icv injections of ANG II on c-Fos and AT(1)-receptor
expression in the rat brain. Am J Physiol Regul Integr Comp
Physiol. 280:R1095–R1104. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Antunes VR, Camargo GM, Saad R, Saad WA,
Luiz AC and Camargo LA: Role of angiotensin II and vasopressin
receptors within the supraoptic nucleus in water and sodium intake
induced by the injection of angiotensin II into the medial septal
area. Braz J Med Biol Res. 31:1597–1600. 1998. View Article : Google Scholar
|
|
35
|
Marciante AB, Wang LA, Farmer GE and
Cunningham JT: Selectively inhibiting the median preoptic nucleus
attenuates angiotensin II and hyperosmotic-induced drinking
behavior and vasopressin release in adult male rats. eNeuro.
6:2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Haywood JR, Fink GD, Buggy J, Boutelle S,
Johnson AK and Brody MJ: Prevention of two-kidney, one-clip renal
hypertension in rat by ablation of AV3V tissue. Am J Physiol.
245:H683–H689. 1983.PubMed/NCBI
|
|
37
|
Schwartz JA, Reilly NS and Knuepfer MM:
Angiotensin and NMDA receptors in the median preoptic nucleus
mediate hemodynamic response patterns to stress. Am J Physiol Regul
Integr Comp Physiol. 295:R155–R165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Eyigor O, Centers A and Jennes L:
Distribution of ionotropic glutamate receptor subunit mRNAs in the
rat hypothalamus. J Comp Neurol. 434:101–124. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Osborn JW, Fink GD, Sved AF, Toney GM and
Raizada MK: Circulating angiotensin II and dietary salt: Converging
signals for neurogenic hypertension. Curr Hypertens Rep. 9:228–235.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Henry M, Grob M and Mouginot D: Endogenous
angiotensin II facilitates GABAergic neurotransmission afferent to
the Na+-responsive neurons of the rat median preoptic
nucleus. Am J Physiol Regul Integr Comp Physiol. 297:R783–R792.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guertzenstein PG and Silver A: Fall in
blood pressure produced from discrete regions of the ventral
surface of the medulla by glycine and lesions. J Physiol.
242:489–503. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Oshima N, Onimaru H, Yamagata A and
Momosawa A: Rostral ventrolateral medulla neuron activity is
suppressed by Klotho and stimulated by FGF23 in newborn Wistar
rats. Auton Neurosci. 224:1026402020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
McAllen RM: Central respiratory modulation
of subretrofacial bulbospinal neurones in the cat. J Physiol.
388:533–545. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ogihara CA, Schoorlemmer GH, Lazari Mde F,
Giannocco G, Lopes OU, Colombari E and Sato MA: Swimming exercise
changes hemodynamic responses evoked by blockade of excitatory
amino receptors in the rostral ventrolateral medulla in
spontaneously hypertensive rats. Biomed Res Int. 2014:4871292014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Dean C and Coote JH: A ventromedullary
relay involved in the hypothalamic and chemoreceptor activation of
sympathetic postganglionic neurones to skeletal muscle, kidney and
splanchnic area. Brain Res. 377:279–285. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dampney RA and McAllen RM: Differential
control of sympathetic fibres supplying hindlimb skin and muscle by
subretrofacial neurones in the cat. J Physiol. 395:41–56. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dean C, Seagard JL, Hopp FA and Kampine
JP: Differential control of sympathetic activity to kidney and
skeletal muscle by ventral medullary neurons. J Auton Nerv Syst.
37:1–10. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lovick TA: Differential control of cardiac
and vasomotor activity by neurones in nucleus paragigantocellularis
lateralis in the cat. J Physiol. 389:23–35. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Barman SM and Gebber GL: Axonal projection
patterns of ventrolateral medullospinal sympathoexcitatory neurons.
J Neurophysiol. 53:1551–1566. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Oliveira RC, Campagnole-Santos MJ and
Santos RA: The pressor effect of angiotensin-(1-7) in the rat
rostral ventrolateral medulla involves multiple peripheral
mechanisms. Clinics (Sao Paulo). 68:245–252. 2013. View Article : Google Scholar
|
|
51
|
Fontes MA, Silva LC, Campagnole-Santos MJ,
Khosla MC, Guertzenstein PG and Santos RA: Evidence that
angiotensin-(1-7) plays a role in the central control of blood
pressure at the ventro-lateral medulla acting through specific
receptors. Brain Res. 665:175–180. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ito S, Hiratsuka M, Komatsu K, Tsukamoto
K, Kanmatsuse K and Sved AF: Ventrolateral medulla AT1 receptors
support arterial pressure in Dahl salt-sensitive rats.
Hypertension. 41:744–750. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ito S, Komatsu K, Tsukamoto K, Kanmatsuse
K and Sved AF: Ventrolateral medulla AT1 receptors support blood
pressure in hypertensive rats. Hypertension. 40:552–559. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Peng JF, Wu ZT, Wang YK, Yuan WJ, Sun T,
Ni X, Su DF, Wang W, Xu MJ and Wang WZ: GABAergic mechanism in the
rostral ventrolateral medulla contributes to the hypotension of
moxonidine. Cardiovasc Res. 89:473–481. 2011. View Article : Google Scholar
|
|
55
|
Sheriff MJ, Fontes MA, Killinger S,
Horiuchi J and Dampney RA: Blockade of AT1 receptors in the rostral
ventrolateral medulla increases sympathetic activity under hypoxic
conditions. Am J Physiol Regul Integr Comp Physiol. 290:R733–R740.
2006. View Article : Google Scholar
|
|
56
|
Nonogaki Z, Umegaki H, Makino T, Suzuki Y
and Kuzuya M: Relationship between cardiac autonomic function and
cognitive function in Alzheimer's disease. Geriatr Gerontol Int.
17:92–98. 2017. View Article : Google Scholar
|
|
57
|
Goldberger JJ, Arora R, Buckley U and
Shivkumar K: Autonomic nervous system dysfunction: JACC focus
seminar. J Am Coll Cardiol. 73:1189–1206. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang LL, Zhang Y, Cheng YQ, Zhang JM, Liu
HQ, Wang WZ, Mehta JL, Xiong ZG, Su DF and Liu AJ: Metabolic
syndrome emerges after artificial selection for low baroreflex
sensitivity. CNS Neurosci Ther. 24:828–836. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Gao L, Schultz HD, Patel KP, Zucker IH and
Wang W: Augmented input from cardiac sympathetic afferents inhibits
baroreflex in rats with heart failure. Hypertension. 45:1173–1181.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhu GQ, Gao L, Li Y, Patel KP, Zucker IH
and Wang W: AT1 receptor mRNA antisense normalizes enhanced cardiac
sympathetic afferent reflex in rats with chronic heart failure. Am
J Physiol Heart Circ Physiol. 287:H1828–H1835. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang WZ, Gao L, Pan YX, Zucker IH and Wang
W: AT1 receptors in the nucleus tractus solitarii mediate the
interaction between the baroreflex and the cardiac sympathetic
afferent reflex in anesthetized rats. Am J Physiol Regul Integr
Comp Physiol. 292:R1137–R1145. 2007. View Article : Google Scholar
|
|
62
|
Nagata S, Kato J, Sasaki K, Minamino N,
Eto T and Kitamura K: Isolation and identification of
proangiotensin-12, a possible component of the renin-angiotensin
system. Biochem Biophys Res Commun. 350:1026–1031. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Diz DI, Garcia-Espinosa MA, Gegick S,
Tommasi EN, Ferrario CM, Ann Tallant E, Chappell MC and Gallagher
PE: Injections of angiotensin-converting enzyme 2 inhibitor MLN4760
into nucleus tractus solitarii reduce baroreceptor reflex
sensitivity for heart rate control in rats. Exp Physiol.
93:694–700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Arnold AC, Isa K, Shaltout HA, Nautiyal M,
Ferrario CM, Chappell MC and Diz DI: Angiotensin-(1-12) requires
angiotensin converting enzyme and AT1 receptors for cardiovascular
actions within the solitary tract nucleus. Am J Physiol Heart Circ
Physiol. 299:H763–H771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Fow JE, Averill DB and Barnes KL:
Mechanisms of angiotensin-induced hypotension and bradycardia in
the medial solitary tract nucleus. Am J Physiol. 267:H259–H266.
1994.PubMed/NCBI
|
|
66
|
Cheung WJ, Kent MA, El-Shahat E, Wang H,
Tan J, White R and Leenen FH: Central and peripheral
renin-angiotensin systems in ouabain-induced hypertension. Am J
Physiol Heart Circ Physiol. 291:H624–H630. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Xin Y, Wu W, Qu J, Wang X, Lei S, Yuan L
and Liu X: Inhibition of mitofusin-2 promotes cardiac fibroblast
activation via the PERK/ATF4 pathway and reactive oxygen species.
Oxid Med Cell Longev. 2019:36498082019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wang D, Lin B, Zhang W and Wang X:
Up-regulation of SNHG16 induced by CTCF accelerates cardiac
hypertrophy by targeting miR-182-5p/IGF1 axis. Cell Biol Int.
44:1426–1435. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Cai W, Zhong S, Zheng F, Zhang Y, Gao F,
Xu H, Cai X, Lan J, Huang D and Shi G: Angiotensin II confers
resistance to apoptosis in cardiac myofibroblasts through the
AT1/ERK1/2/RSK1 pathway. IUBMB Life. 71:261–276. 2019. View Article : Google Scholar
|
|
70
|
Alanazi AZ and Clark MA: Angiotensin III
induces JAK2/STAT3 leading to IL-6 production in rat vascular
smooth muscle cells. Int J Mol Sci. 20:55512019. View Article : Google Scholar :
|
|
71
|
Chang L, Yang R, Wang M, Liu J, Wang Y,
Zhang H and Li Y: Angiotensin II type-1 receptor-JAK/STAT pathway
mediates the induction of visfatin in angiotensin II-induced
cardiomyocyte hypertrophy. Am J Med Sci. 343:220–226. 2012.
View Article : Google Scholar
|
|
72
|
Mascareno E and Siddiqui MA: The role of
Jak/STAT signaling in heart tissue renin-angiotensin system. Mol
Cell Biochem. 212:171–175. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wang TL, Yang YH, Chang H and Hung CR:
Angiotensin II signals mechanical stretch-induced cardiac matrix
metalloproteinase expression via JAK-STAT pathway. J Mol Cell
Cardiol. 37:785–794. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ali MS, Sayeski PP, Dirksen LB, Hayzer DJ,
Marrero MB and Bernstein KE: Dependence on the motif YIPP for the
physical association of Jak2 kinase with the intracellular carboxyl
tail of the angiotensin II AT1 receptor. J Biol Chem.
272:23382–23388. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Frank GD, Saito S, Motley ED, Sasaki T,
Ohba M, Kuroki T, Inagami T and Eguchi S: Requirement of Ca(2+) and
PKCdelta for Janus kinase 2 activation by angiotensin II:
Involvement of PYK2. Mol Endocrinol. 16:367–377. 2002.PubMed/NCBI
|
|
76
|
Balakumar P and Jagadeesh G: A century old
renin-angiotensin system still grows with endless possibilities:
AT1 receptor signaling cascades in cardiovascular physiopathology.
Cell Signal. 26:2147–2160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Fung NH, Grima CA, Widodo SS, Kaye AH,
Whitehead CA, Stylli SS and Mantamadiotis T: Understanding and
exploiting cell signalling convergence nodes and pathway cross-talk
in malignant brain cancer. Cell Signal. 57:2–9. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Gaborik Z and Hunyady L: Intracellular
trafficking of hormone receptors. Trends Endocrinol Metab.
15:286–293. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Luttrell LM and Lefkowitz RJ: The role of
beta-arrestins in the termination and transduction of
G-protein-coupled receptor signals. J Cell Sci. 115:455–465.
2002.PubMed/NCBI
|
|
80
|
Dasgupta C and Zhang L: Angiotensin II
receptors and drug discovery in cardiovascular disease. Drug Discov
Today. 16:22–34. 2011. View Article : Google Scholar :
|
|
81
|
Wei H, Ahn S, Shenoy SK, Karnik SS,
Hunyady L, Luttrell LM and Lefkowitz RJ: Independent beta-arrestin
2 and G protein-mediated pathways for angiotensin II activation of
extracellular signal-regulated kinases 1-2. Proc Natl Acad Sci USA.
100:10782–10787. 2003. View Article : Google Scholar
|
|
82
|
Hunton DL, Barnes WG, Kim J, Ren XR,
Violin JD, Reiter E, Milligan G, Patel DD and Lefkowitz RJ:
Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated
pathway of chemotaxis. Mol Pharmacol. 67:1229–1236. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Wei SG, Yu Y, Zhang ZH and Felder RB:
Angiotensin II upregulates hypothalamic AT1 receptor expression in
rats via the mitogen-activated protein kinase pathway. Am J Physiol
Heart Circ Physiol. 296:H1425–H1433. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Callera GE, Touyz RM, Tostes RC, Yogi A,
He Y, Malkinson S and Schiffrin EL: Aldosterone activates vascular
p38MAP kinase and NADPH oxidase via c-Src. Hypertension.
45:773–779. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Zhang ZH, Yu Y, Kang YM, Wei SG and Felder
RB: Aldosterone acts centrally to increase brain renin-angiotensin
system activity and oxidative stress in normal rats. Am J Physiol
Heart Circ Physiol. 294:H1067–H1074. 2008. View Article : Google Scholar
|
|
86
|
Vrábel D, Pour L and Ševčíková S: The
impact of NF-κB signaling on pathogenesis and current treatment
strategies in multiple myeloma. Blood Rev. 34:56–66. 2019.
View Article : Google Scholar
|
|
87
|
Pioli MR and de Faria AP: Pro-inflammatory
cytokines and resistant hypertension: Potential for novel
treatments? Curr Hypertens Rep. 21:952019. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Pendergrass KD, Pirro NT, Westwood BM,
Ferrario CM, Brosnihan KB and Chappell MC: Sex differences in
circulating and renal angiotensins of hypertensive mRen(2) Lewis
but not normotensive Lewis rats. Am J Physiol Heart Circ Physiol.
295:H10–H20. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Zhang ZH, Wei SG, Francis J and Felder RB:
Cardiovascular and renal sympathetic activation by blood-borne
TNF-alpha in rat: The role of central prostaglandins. Am J Physiol
Regul Integr Comp Physiol. 284:R916–R927. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kang YM, Ma Y, Zheng JP, Elks C, Sriramula
S, Yang ZM and Francis J: Brain nuclear factor-kappa B activation
contributes to neurohumoral excitation in angiotensin II-induced
hypertension. Cardiovasc Res. 82:503–512. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Du N, Feng J, Hu LJ, Sun X, Sun HB, Zhao
Y, Yang YP and Ren H: Angiotensin II receptor type 1 blockers
suppress the cell proliferation effects of angiotensin II in breast
cancer cells by inhibiting AT1R signaling. Oncol Rep. 27:1893–1903.
2012.PubMed/NCBI
|
|
92
|
Donohoe F, Wilkinson M, Baxter E and
Brennan DJ: Mitogen-activated protein kinase (MAPK) and
obesity-related cancer. Int J Mol Sci. 21:12412020. View Article : Google Scholar :
|
|
93
|
Grewal SS, Horgan AM, York RD, Withers GS,
Banker GA and Stork PJ: Neuronal calcium activates a Rap1 and B-Raf
signaling pathway via the cyclic adenosine monophosphate-dependent
protein kinase. J Biol Chem. 275:3722–3728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Averill DB and Diz DI: Angiotensin
peptides and baroreflex control of sympathetic outflow: Pathways
and mechanisms of the medulla oblongata. Brain Res Bull.
51:119–128. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Han NL and Sim MK: Hypothalamic
angiotensin receptor subtypes in normotensive and hypertensive
rats. Am J Physiol. 275:H703–H709. 1998.PubMed/NCBI
|
|
96
|
Lu D, Sumners C and Raizada MK: Regulation
of angiotensin II type 1 receptor mRNA in neuronal cultures of
normotensive and spontaneously hypertensive rat brains by phorbol
esters and forskolin. J Neurochem. 62:2079–2084. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Phillips MI and Kimura B: Converting
enzyme inhibitors and brain angiotensin. J Cardiovasc Pharmacol.
8(Suppl 10): S82–S90. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Gyurko R, Wielbo D and Phillips MI:
Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA
in the brain of spontaneously hypertensive rats reduces
hypertension of neurogenic origin. Regul Pept. 49:167–174. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Sun C, Du J, Sumners C and Raizada MK:
PI3-kinase inhibitors abolish the enhanced chronotropic effects of
angiotensin II in spontaneously hypertensive rat brain neurons. J
Neurophysiol. 90:3155–3160. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Perfumi M, Sajia A, Costa G, Massi M and
Polidori C: Vasopressin release induced by intracranial injection
of eledoisin is mediated by central angiotensin II. Pharmacol Res
Commun. 20:811–826. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Sumners C, Fleegal MA and Zhu M:
Angiotensin AT1 receptor signalling pathways in neurons. Clin Exp
Pharmacol Physiol. 29:483–490. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Lu D and Raizada MK: Delivery of
angiotensin II type 1 receptor antisense inhibits angiotensin
action in neurons from hypertensive rat brain. Proc Natl Acad Sci
USA. 92:2914–2918. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Lu D, Yang H, Lenox RH and Raizada MK:
Regulation of angiotensin II-induced neuromodulation by MARCKS in
brain neurons. J Cell Biol. 142:217–227. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Yang H and Raizada MK: Role of
phosphatidylinositol 3-kinase in angiotensin II regulation of
norepinephrine neuromodulation in brain neurons of the
spontaneously hypertensive rat. J Neurosci. 19:2413–2423. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Seyedabadi M, Goodchild AK and Pilowsky
PM: Differential role of kinases in brain stem of hypertensive and
normotensive rats. Hypertension. 38:1087–1092. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Wang YK, Yu Q, Tan X, Wu ZT, Zhang RW,
Yang YH, Yuan WJ, Hu QK and Wang WZ: Centrally acting drug
moxonidine decreases reactive oxygen species via inactivation of
the phosphoinositide-3 kinase signaling in the rostral
ventrolateral medulla in hypertensive rats. J Hypert. 34:993–1004.
2016. View Article : Google Scholar
|
|
107
|
Azegami T and Itoh H: Vaccine development
against the renin-angiotensin system for the treatment of
hypertension. Int J Hypertens. 2019:92185312019. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Leenen FH and Yuan B: Prevention of
hypertension by irbesartan in Dahl S rats relates to central
angiotensin II type 1 receptor blockade. Hypertension. 37:981–984.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Adams JM, McCarthy JJ and Stocker SD:
Excess dietary salt alters angiotensinergic regulation of neurons
in the rostral ventrolateral medulla. Hypertension. 52:932–937.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
DiBona GF and Jones SY: Sodium intake
influences hemodynamic and neural responses to angiotensin receptor
blockade in rostral ventrolateral medulla. Hypertension.
37:1114–1123. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
DiBona GF and Jones SY: Effect of dietary
sodium intake on central angiotensinergic pathways. Auton Neurosci.
98:17–19. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Nagayama T, Hirooka Y, Kishi T, Mukai Y,
Inoue S, Takase S, Takemoto M, Chishaki A and Sunagawa K: Blockade
of brain angiotensin II type 1 receptor inhibits the development of
atrial fibrillation in hypertensive rats. Am J Hypertens.
28:444–451. 2015. View Article : Google Scholar
|
|
113
|
Zhao X, White R, Huang BS, Van Huysse J
and Leenen FH: High salt intake and the brain renin-angiotensin
system in Dahl salt-sensitive rats. J Hypertens. 19:89–98. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Olivares-Reyes JA, Arellano-Plancarte A
and Castillo-Hernandez JR: Angiotensin II and the development of
insulin resistance: Implications for diabetes. Mol Cell Endocrinol.
302:128–139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
de Ferranti S and Mozaffarian D: The
perfect storm: Obesity, adipocyte dysfunction, and metabolic
consequences. Clin Chem. 54:945–955. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Cole BK, Keller SR, Wu R, Carter JD,
Nadler JL and Nunemaker CS: Valsartan protects pancreatic islets
and adipose tissue from the inflammatory and metabolic consequences
of a high-fat diet in mice. Hypertension. 55:715–721. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Kanda H, Tateya S, Tamori Y, Kotani K,
Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K and
Kasuga M: MCP-1 contributes to macrophage infiltration into adipose
tissue, insulin resistance, and hepatic steatosis in obesity. J
Clin Invest. 116:1494–1505. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Kucan M, Mrsic-Pelcic J and Vitezic D:
Antihypertensive drugs in croatia: What changes the drug usage
patterns? Clin Ther. 40:1159–1169. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Yang H, Bai S, Wu Y, Li Q, Luo F, Li B,
Jin Y and Xiao C: Polymorphisms within angiotensin II receptor type
1 gene associated with essential hypertension in Chinese Hani and
Yi minorities. J Renin Angiotensin Aldosterone Syst. 16:653–659.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Nakaya H, Sasamura H, Kitamura Y, Amemiya
T, Konishi K, Hayashi M and Saruta T: Effects of angiotensin
inhibitors on renal injury and angiotensin receptor expression in
early hypertensive nephrosclerosis. Hypertens Res. 22:303–312.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Katovich MJ, Gelband CH, Reaves P, Wang HW
and Raizada MK: Reversal of hypertension by angiotensin II type 1
receptor antisense gene therapy in the adult SHR. Am J Physiol.
277:H1260–H1264. 1999.PubMed/NCBI
|
|
122
|
Zhi JM, Liu ZB, Jiao XY, Liu YX and Zhao
RR: Effect of losartan on produce of sera autoantibodies to
angiotensin II-1 receptor in renovascular hypertension rats.
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 19:43–46. 2003.In Chinese.
PubMed/NCBI
|
|
123
|
Bender SB, McGraw AP, Jaffe IZ and Sowers
JR: Mineralocorticoid receptor-mediated vascular insulin
resistance: An early contributor to diabetes-related vascular
disease? Diabetes. 62:313–319. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Malik RA, Schofield IJ, Izzard A, Austin
C, Bermann G and Heagerty AM: Effects of angiotensin type-1
receptor antago- nism on small artery function in patients with
type 2 diabetes mellitus. Hypertension. 45:264–269. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Tabony AM, Yoshida T, Galvez S, Higashi Y,
Sukhanov S, Chandrasekar B, Mitch WE and Delafontaine P:
Angiotensin II upregulates protein phosphatase 2Cα and inhibits
AMP-activated protein kinase signaling and energy balance leading
to skeletal muscle wasting. Hypertension. 58:643–649. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Van Linthout S, Spillmann F, Lorenz M,
Meloni M, Jacobs F, Egorova M, Stangl V, De Geest B, Schultheiss HP
and Tschöpe C: Vascular-protective effects of high-density
lipoprotein include the downregulation of the angiotensin II type 1
receptor. Hypertension. 53:682–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Akishita M, Horiuchi M, Yamada H, Zhang L,
Shirakami G, Tamura K, Ouchi Y and Dzau VJ: Inflammation influences
vascular remodeling through AT2 receptor expression and signaling.
Physiol Genomics. 2:13–20. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Kamo T, Akazawa H and Komuro I:
Pleiotropic effects of angiotensin II receptor signaling in
cardiovascular homeostasis and aging. Int Heart J. 56:249–254.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Hannan RE, Davis EA and Widdop RE:
Functional role of angiotensin II AT2 receptor in modulation of AT1
receptor-mediated contraction in rat uterine artery: Involvement of
bradykinin and nitric oxide. Br J Pharmacol. 140:987–995. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Lee JH, Xia S and Ragolia L: Upregulation
of AT2 receptor and iNOS impairs angiotensin II-induced contraction
without endothelium influence in young normotensive diabetic rats.
Am J Physiol Regul Integr Comp Physiol. 295:R144–R154. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Hanff E, Ruben S, Kreuzer M, Bollenbach A,
Kayacelebi AA, Das AM, von Versen-Höynck F, von Kaisenberg C,
Haffner D, Ückert S and Tsikas D: Development and validation of
GC-MS methods for the comprehensive analysis of amino acids in
plasma and urine and applications to the HELLP syndrome and
pediatric kidney transplantation: Evidence of altered methylation,
transamidination, and arginase activity. Amino Acids. 51:529–547.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Łuszczki JJ, Jaskólska A, Dworzański W and
Zółkowska D: 7-Nitroindazole, but not NG-nitro-L-arginine, enhances
the anticonvulsant activity of pregabalin in the mouse maximal
electroshock-induced seizure model. Pharmacol Rep. 63:169–175.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Miguel-Carrasco JL, Mate A, Monserrat MT,
Arias JL, Aramburu O and Vázquez CM: The role of inflammatory
markers in the cardioprotective effect of L-carnitine in
L-NAME-induced hypertension. Am J Hypertens. 21:1231–1237. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Carey RM: AT2 receptors: Potential
therapeutic targets for hypertension. Am J Hypertens. 30:339–347.
2017.
|
|
135
|
Savoia C, Ebrahimian T, He Y, Gratton JP,
Schiffrin EL and Touyz RM: Angiotensin II/AT2 receptor-induced
vasodilation in stroke-prone spontaneously hypertensive rats
involves nitric oxide and cGMP-dependent protein kinase. J
Hypertens. 24:2417–2422. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Cosentino F, Savoia C, De Paolis P,
Francia P, Russo A, Maffei A, Venturelli V, Schiavoni M, Lembo G
and Volpe M: Angiotensin II type 2 receptors contribute to vascular
responses in spontaneously hypertensive rats treated with
angiotensin II type 1 receptor antagonists. Am J Hypertens.
18:493–499. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Kulkarni S, O'Farrell I, Erasi M and
Kochar MS: Stress and hypertension. WMJ. 97:34–38. 1998.
|
|
138
|
Epstein OI, Martyushev AV, Kudryashova DR,
Markel AL, Sergeeva SA and Shtark MB: Hypotensive effect of
potentiated antibodies to angiotensin II and AT1 receptors. Bull
Exp Biol Med. 135(Suppl 7): S62–S64. 2003. View Article : Google Scholar
|
|
139
|
Nickenig G and Harrison DG: The AT(1)-type
angiotensin receptor in oxidative stress and atherogenesis: Part
II: AT(1) receptor regulation. Circulation. 105:530–536. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Hosomi N, Nishiyama A, Ban CR, Naya T,
Takahashi T, Kohno M and Koziol JA: Angiotensin type 1 receptor
blockage improves ischemic injury following transient focal
cerebral ischemia. Neuroscience. 134:225–231. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Iwai M, Liu HW, Chen R, Ide A, Okamoto S,
Hata R, Sakanaka M, Shiuchi T and Horiuchi M: Possible inhibition
of focal cerebral ischemia by angiotensin II type 2 receptor
stimulation. Circulation. 110:843–848. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Maeda K, Hata R, Bader M, Walther T and
Hossmann KA: Larger anastomoses in angiotensinogen-knockout mice
attenuate early metabolic disturbances after middle cerebral artery
occlusion. J Cereb Blood Flow Metab. 19:1092–1098. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Chen S, Li G, Zhang W, Wang J, Sigmund CD,
Olson JE and Chen Y: Ischemia-induced brain damage is enhanced in
human renin and angiotensinogen double-transgenic mice. Am J
Physiol Regul Integr Comp Physiol. 297:R1526–R1531. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Guzik TJ, Hoch NE, Brown KA, McCann LA,
Rahman A, Dikalov S, Goronzy J, Weyand C and Harrison DG: Role of
the T cell in the genesis of angiotensin II induced hypertension
and vascular dysfunction. J Exp Med. 204:2449–2460. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Nagai M, Terao S, Vital SA, Rodrigues SF,
Yilmaz G and Granger DN: Role of blood cell-associated angiotensin
II type 1 receptors in the cerebral microvascular response to
ischemic stroke during angiotensin-induced hypertension. Exp Transl
Stroke Med. 3:152011. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Walther T, Olah L, Harms C, Maul B, Bader
M, Hörtnagl H, Schultheiss HP and Mies G: Ischemic injury in
experimental stroke depends on angiotensin II. FASEB J. 16:169–176.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Kitiyakara C and Guzman NJ: Malignant
hypertension and hypertensive emergencies. J Am Soc Nephrol.
9:133–142. 1998.PubMed/NCBI
|
|
148
|
Fleegal-DeMotta MA, Doghu S and Banks WA:
Angiotensin II modulates BBB permeability via activation of the
AT(1) receptor in brain endothelial cells. J Cereb Blood Flow
Metab. 29:640–647. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Vital SA, Terao S, Nagai M and Granger DN:
Mechanisms underlying the cerebral microvascular responses to
angiotensin II-induced hypertension. Microcirculation. 17:641–649.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Perazella MA and Setaro JF:
Renin-angiotensin-aldosterone system: Fundamental aspects and
clinical implications in renal and cardiovascular disorders. J Nucl
Cardiol. 10:184–196. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Sato A, Saruta T and Funder JW:
Combination therapy with aldosterone blockade and renin-angiotensin
inhibitors confers organ protection. Hypertens Res. 29:211–216.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Harada E, Yoshimura M, Yasue H, Nakagawa
O, Nakagawa M, Harada M, Mizuno Y, Nakayama M, Shimasaki Y, Ito T,
et al: Aldosterone induces angiotensin-converting-enzyme gene
expression in cultured neonatal rat cardiocytes. Circulation.
104:137–139. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Ullian ME, Schelling JR and Linas SL:
Aldosterone enhances angiotensin II receptor binding and inositol
phosphate responses. Hypertension. 20:67–73. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Yu Y, Wei SG, Zhang ZH, Gomez-Sanchez E,
Weiss RM and Felder RB: Does aldosterone upregulate the brain
renin-angiotensin system in rats with heart failure? Hypertension.
51:727–733. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Xue B, Beltz TG, Yu Y, Guo F,
Gomez-Sanchez CE, Hay M and Johnson AK: Central interactions of
aldosterone and angiotensin II in aldosterone- and angiotensin
II-induced hypertension. Am J Physiol Heart Circ Physiol.
300:H555–H564. 2011. View Article : Google Scholar :
|
|
156
|
Bomback AS and Klemmer PJ: The incidence
and implications of aldosterone breakthrough. Nat Clin Pract
Nephrol. 3:486–492. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Park S, Nguyen NB, Pezhouman A and
Ardehali R: Cardiac fibrosis: Potential therapeutic targets. Transl
Res. 209:121–137. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Jia G, Aroor AR, Hill MA and Sowers JR:
Role of renin-angiotensin-aldosterone system activation in
promoting cardiovascular fibrosis and stiffness. Hypertension.
72:537–548. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Li XC, Zhang J and Zhuo JL: The
vasoprotective axes of the renin-angiotensin system: Physiological
relevance and therapeutic implications in cardiovascular,
hypertensive and kidney diseases. Pharmacol Res. 125:21–38. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Yatabe J, Yoneda M, Yatabe MS, Watanabe T,
Felder RA, Jose PA and Sanada H: Angiotensin III stimulates
aldosterone secretion from adrenal gland partially via angiotensin
II type 2 receptor but not angiotensin II type 1 receptor.
Endocrinology. 152:1582–1588. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Kopf PG, Park SK, Herrnreiter A, Krause C,
Roques BP and Campbell WB: Obligatory metabolism of angiotensin II
to angiotensin III for zona glomerulosa cell-mediated relaxations
of bovine adrenal cortical arteries. Endocrinology. 159:238–247.
2018. View Article : Google Scholar
|
|
162
|
Plovsing RR, Wamberg C, Sandgaard NC,
Simonsen JA, Holstein-Rathlou NH, Hoilund-Carlsen PF and Bie P:
Effects of truncated angiotensins in humans after double blockade
of the renin system. Am J Physiol Regul Integr Comp Physiol.
285:R981–R991. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Tang L, Zheng S, Ren H, He D, Zeng C and
Wang WE: Activation of angiotensin II type 1 receptors increases D4
dopamine receptor expression in rat renal proximal tubule cells.
Hypertens Res. 40:652–657. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Kouyoumdzian NM, Rukavina Mikusic NL,
Robbesaul GD, Gorzalczany SB, Carranza A, Trida V, Fernández BE and
Choi MR: Acute infusion of angiotensin II regulates organic cation
transporters function in the kidney: Its impact on the renal
dopaminergic system and sodium excretion. Hypertens Res.
44:286–298. 2021. View Article : Google Scholar
|
|
165
|
Zeng C and Jose PA: Dopamine receptors:
Important anti- hypertensive counterbalance against hypertensive
factors. Hypertension. 57:11–17. 2011. View Article : Google Scholar
|
|
166
|
Li D, Scott L, Crambert S, Zelenin S,
Eklöf AC, Di Ciano L, Ibarra F and Aperia A: Binding of losartan to
angiotensin AT1 receptors increases dopamine D1 receptor
activation. J Am Soc Nephrol. 23:421–428. 2012. View Article : Google Scholar :
|
|
167
|
Nakaya H, Sasamura H, Hayashi M and Saruta
T: Temporary treatment of prepubescent rats with angiotensin
inhibitors suppresses the development of hypertensive
nephrosclerosis. J Am Soc Nephrol. 12:659–666. 2001.PubMed/NCBI
|
|
168
|
Iwasaki Y, Ichikawa Y, Igarashi O,
Kinoshita M and Ikeda K: Trophic effect of olmesartan, a novel AT1R
antagonist, on spinal motor neurons in vitro and in vivo. Neurol
Res. 24:468–472. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Moudgil R, Musat-Marcu S, Xu Y, Kumar D
and Jugdutt BI: Increased AT2R protein expression but not increased
apoptosis during cardioprotection induced by AT1R blockade. Can J
Cardiol. 18:873–883. 2002.PubMed/NCBI
|
|
170
|
Lacourcière Y, Poirier L and Lefebvre J: A
comparative review of the efficacy of antihypertensive agents on 24
h ambulatory blood pressure. Can J Cardiol. 16:1155–1166.
2000.PubMed/NCBI
|
|
171
|
Azizi M, Ménard J, Bissery A, Guyenne TT,
Bura-Rivière A, Vaidyanathan S and Camisasca RP: Pharmacologic
demonstration of the synergistic effects of a combination of the
renin inhibitor aliskiren and the AT1 receptor antagonist valsartan
on the angiotensin II-renin feedback interruption. J Am Soc
Nephrol. 15:3126–3133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Grammatopoulos TN, Ahmadi F, Jones SM,
Fariss MW, Weyhenmeyer JA and Zawada WM: Angiotensin II protects
cultured midbrain dopaminergic neurons against rotenone-induced
cell death. Brain Res. 1045:64–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
de Oliveira-Sales EB, Nishi EE, Boim MA,
Dolnikoff MS, Bergamaschi CT and Campos RR: Upregulation of AT1R
and iNOS in the rostral ventrolateral medulla (RVLM) is essential
for the sympathetic hyperactivity and hypertension in the 2K-1C
Wistar rat model. Am J Hypertens. 23:708–715. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Widdop RE, Matrougui K, Levy BI and
Henrion D: AT2 receptor-mediated relaxation is preserved after
long-term AT1 receptor blockade. Hypertension. 40:516–520. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Moudgil R, Menon V, Xu Y, Musat-Marcu S,
Kumar D and Jugdutt BI: Postischemic apoptosis and functional
recovery after angiotensin II type 1 receptor blockade in isolated
working rat hearts. J Hypertens. 19:1121–1129. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Kumagai K, Nakashima H, Urata H, Gondo N,
Arakawa K and Saku K: Effects of angiotensin II type 1 receptor
antagonist on electrical and structural remodeling in atrial
fibrillation. J Am Coll Cardiol. 41:2197–2204. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Barki-Harrington L, Luttrell LM and
Rockman HA: Dual inhibition of beta-adrenergic and angiotensin II
receptors by a single antagonist: A functional role for
receptor-receptor interaction in vivo. Circulation. 108:1611–1618.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Ismail MA, Barker S, Abou el-Ella DA,
Abouzid KA, Toubar RA and Todd MH: Design and synthesis of new
tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one
derivatives as angiotensin II AT1 receptor antagonists. J Med Chem.
49:1526–1535. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Kaur N, Kaur A, Bansal Y, Shah DI, Bansal
G and Singh M: Design, synthesis, and evaluation of 5-sulfamoyl
benzimidazole derivatives as novel angiotensin II receptor
antagonists. Bioorg Med Chem. 16:10210–10215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Matsoukas JM, Agelis G, Hondrelis J,
Yamdagni R, Wu Q, Ganter R, Smith JR, Moore D and Moore GJ:
Synthesis and biological activities of angiotensin II, Sarilesin,
and Sarmesin analogues containing Aze or Pip at position 7. J Med
Chem. 36:904–911. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Matsoukas JM, Agelis G, Wahhab A,
Hondrelis J, Panagiotopoulos D, Yamdagni R, Wu Q, Mavromoustakos T,
Maia HL, Ganter R, et al: Differences in backbone structure between
angiotensin II agonists and type I antagonists. J Med Chem.
38:4660–4669. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Zoumpoulakis P, Zoga A, Roumelioti P,
Giatas N, Grdadolnik SG, Iliodromitis E, Vlahakos D, Kremastinos D,
Matsoukas JM and Mavromoustakos T: Conformational and biological
studies for a pair of novel synthetic AT1 antagonists:
Stereoelectronic requirements for antihypertensive efficacy. J
Pharm Biomed Anal. 31:833–844. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Phillips MI and Kimura B: Gene therapy for
hypertension: Antisense inhibition of the renin-angiotensin system.
Methods Mol Med. 108:363–379. 2005.PubMed/NCBI
|
|
184
|
Li XG, Yan JT, Xu XZ, Wang JN, Cheng LM,
Wang T, Zuo P and Wang DW: Recombinant adeno-associated
virus-mediated delivery of antisense angiotensin II receptor 1 gene
attenuates hypertension development. Acta Pharmacol Sin.
28:1737–1745. 2007. View Article : Google Scholar : PubMed/NCBI
|
